By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


Key Statistics

Ownership: Public

Web Site: AVEO Oncology
Symbol: AVEO


Merck & Co.  Cancer

Company News
Clinical Data On AVEO Oncology (AVEO)’s Ficlatuzumab And Tivozanib To Be Presented At The ESMO 2014 Congress 9/17/2014 12:54:59 PM
Ex-AVEO Oncology (AVEO) Executive Takes COO Job At Biotech Startup Scholar Rock 9/15/2014 6:33:25 AM
AVEO Oncology (AVEO) Reports Second Quarter 2014 Financial Results And Updates Progress On Strategic Plan 8/12/2014 8:39:00 AM
AVEO Oncology (AVEO) Announces Presentation Of AV-203 Phase 1 Results At 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 9:32:53 AM
AVEO Oncology (AVEO) To Present At The Jefferies and Co. Global Healthcare Conference 5/28/2014 7:24:54 AM
AVEO Oncology (AVEO) Reports First Quarter 2014 Financial Results 5/8/2014 8:56:21 AM
AVEO Oncology (AVEO) To Report First Quarter 2014 Financial Results On May 7, 2014 5/5/2014 6:59:27 AM
AVEO Oncology (AVEO), Biodesix, Inc. Strike Ficlatuzumab-Companion Diagnostic Pact, Bioesix To Put Up An Initial $15 Million To Fund Study 4/10/2014 6:57:50 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) Hands Back Cancer Drug Rights To Struggling AVEO Oncology (AVEO) 3/21/2014 7:08:06 AM
AVEO Oncology (AVEO) Reports Full Year 2013 Financial Results And Outlines 2014 Strategic Plan 3/14/2014 6:50:13 AM